Variant report

Variant	nsv1058772
Chromosome Location	chr19:41437946-41500915
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41486058-41486085	HepG2	liver:	n/a	n/a
2	ATF1	chr19:41468671-41468771	K562	blood:	n/a	n/a
3	ATF3	chr19:41468329-41468885	A549	lung:	n/a	n/a
4	BACH1	chr19:41488176-41489166	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr19:41437946-41438301	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr19:41437956-41438260	K562	blood:	n/a	n/a
7	BCL3	chr19:41468223-41469050	A549	lung:	n/a	n/a
8	BCL3	chr19:41468291-41469001	A549	lung:	n/a	n/a
9	BRCA1	chr19:41465957-41466156	GM12878	blood:	n/a	n/a
10	CBX3	chr19:41482345-41482685	K562	blood:	n/a	n/a
11	CBX3	chr19:41460404-41460899	K562	blood:	n/a	n/a
12	CBX3	chr19:41460434-41460907	K562	blood:	n/a	n/a
13	CEBPB	chr19:41438614-41439244	K562	blood:	n/a	n/a
14	CEBPB	chr19:41468165-41469078	A549	lung:	n/a	chr19:41468797-41468810
15	CEBPB	chr19:41438982-41439268	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr19:41438908-41439279	K562	blood:	n/a	n/a
17	CEBPB	chr19:41468308-41469019	Hela-S3	cervix:	n/a	chr19:41468797-41468810
18	CEBPB	chr19:41486262-41486477	HepG2	liver:	n/a	n/a
19	CEBPB	chr19:41438733-41439296	A549	lung:	n/a	n/a
20	CEBPB	chr19:41488481-41488681	Hela-S3	cervix:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
21	CEBPB	chr19:41488438-41488777	K562	blood:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
22	CEBPB	chr19:41488422-41488791	A549	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
23	CEBPB	chr19:41488434-41488797	HepG2	liver:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
24	CEBPB	chr19:41488408-41488845	MCF-7	breast:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
25	CEBPB	chr19:41468360-41468789	A549	lung:	n/a	n/a
26	CEBPB	chr19:41488522-41488635	HepG2	liver:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
27	CEBPB	chr19:41488440-41489019	H1-hESC	embryonic stem cell:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
28	CEBPB	chr19:41488308-41488880	A549	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
29	CEBPB	chr19:41486382-41486422	K562	blood:	n/a	n/a
30	CEBPB	chr19:41468301-41468559	HepG2	liver:	n/a	n/a
31	CEBPB	chr19:41488441-41488804	IMR90	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
32	CEBPB	chr19:41446714-41446729	A549	lung:	n/a	n/a
33	CEBPD	chr19:41458422-41458815	K562	blood:	n/a	n/a
34	CHD2	chr19:41465957-41466157	K562	blood:	n/a	n/a
35	CREB1	chr19:41468563-41468752	A549	lung:	n/a	n/a
36	CREB1	chr19:41486321-41486531	H1-hESC	embryonic stem cell:	n/a	n/a
37	CTCF	chr19:41450236-41450381	MCF-7	breast:	n/a	n/a
38	CTCF	chr19:41480580-41480730	BJ	skin:	n/a	chr19:41480643-41480659 chr19:41480644-41480665 chr19:41480645-41480658 chr19:41480645-41480658 chr19:41480647-41480657 chr19:41480645-41480654 chr19:41480642-41480660
39	CTCF	chr19:41480540-41480690	HPAF	blood vessel:	n/a	chr19:41480643-41480659 chr19:41480644-41480665 chr19:41480645-41480658 chr19:41480645-41480658 chr19:41480647-41480657 chr19:41480645-41480654 chr19:41480642-41480660
40	CTCF	chr19:41494642-41494665	GM13976	blood:	n/a	n/a
41	CTCF	chr19:41438972-41439283	K562	blood:	n/a	n/a
42	CTCF	chr19:41437073-41439938	A549	lung:	n/a	n/a
43	CTCF	chr19:41480580-41480730	HCM	heart:	n/a	chr19:41480643-41480659 chr19:41480644-41480665 chr19:41480645-41480658 chr19:41480645-41480658 chr19:41480647-41480657 chr19:41480645-41480654 chr19:41480642-41480660
44	CTCF	chr19:41439085-41439127	GM19240	blood:	n/a	n/a
45	CTCF	chr19:41480580-41480730	AG09309	skin:	n/a	chr19:41480643-41480659 chr19:41480644-41480665 chr19:41480645-41480658 chr19:41480645-41480658 chr19:41480647-41480657 chr19:41480645-41480654 chr19:41480642-41480660
46	CTCF	chr19:41439020-41439170	HPAF	blood vessel:	n/a	n/a
47	CTCF	chr19:41480501-41480805	Spleen_OC	spleen:	n/a	chr19:41480643-41480659 chr19:41480644-41480665 chr19:41480645-41480658 chr19:41480645-41480658 chr19:41480647-41480657 chr19:41480645-41480654 chr19:41480642-41480660
48	CTCF	chr19:41480405-41480787	HepG2	liver:	n/a	chr19:41480643-41480659 chr19:41480644-41480665 chr19:41480645-41480658 chr19:41480645-41480658 chr19:41480647-41480657 chr19:41480645-41480654 chr19:41480642-41480660
49	CTCF	chr19:41480560-41480710	AG09309	skin:	n/a	chr19:41480643-41480659 chr19:41480644-41480665 chr19:41480645-41480658 chr19:41480645-41480658 chr19:41480647-41480657 chr19:41480645-41480654 chr19:41480642-41480660
50	CTCF	chr19:41439000-41439150	HVMF	connective:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41496749-41496799	AoSMC	blood vessel:	n/a
2	chr19:41496749-41496799	RPTEC	kidney:	n/a
3	chr19:41497222-41497272	MCF10A-Er-Src	breast:	n/a
4	chr19:41497222-41497272	AG09309	skin:	n/a
5	chr19:41496749-41496799	SKMC	muscle:	n/a
6	chr19:41496749-41496799	AG04450	lung:	fetal
7	chr19:41495942-41495992	Hepatocyte	liver:	n/a
8	chr19:41495942-41495992	AG04449	skin:	fetal
9	chr19:41496749-41496799	BJ	skin:	n/a
10	chr19:41497222-41497272	HUVEC	blood vessel:	n/a
11	chr19:41496749-41496799	LNCaP	prostate:	n/a
12	chr19:41496749-41496799	NB4	blood:	n/a
13	chr19:41495942-41495992	NHDF-neo	bronchial:	n/a
14	chr19:41497222-41497272	HRCEpiC	kidney:	n/a
15	chr19:41495942-41495992	LNCaP	prostate:	n/a
16	chr19:41496043-41496093	HRE	kidney:	n/a
17	chr19:41496749-41496799	ECC-1	luminal epithelium:	n/a
18	chr19:41496749-41496799	HCM	heart:	n/a
19	chr19:41496043-41496093	A549	lung:	n/a
20	chr19:41496043-41496093	SK-N-MC	brain:	n/a
21	chr19:41495942-41495992	RPTEC	kidney:	n/a
22	chr19:41497222-41497272	ovcar-3	ovarian:	n/a
23	chr19:41496043-41496093	NT2-D1	testis:	n/a
24	chr19:41495942-41495992	MCF10A-Er-Src	breast:	n/a
25	chr19:41496749-41496799	NHBE	bronchial:	n/a
26	chr19:41496749-41496799	Hepatocyte	liver:	n/a
27	chr19:41496043-41496093	NH-A	brain:	n/a
28	chr19:41495942-41495992	Jurkat	blood:	n/a
29	chr19:41495942-41495992	T-47D	breast:	n/a
30	chr19:41497222-41497272	RPTEC	kidney:	n/a
31	chr19:41497222-41497272	GM12892	blood:	n/a
32	chr19:41496749-41496799	BE2_C	brain:	n/a
33	chr19:41497222-41497272	MCF-7	breast:	n/a
34	chr19:41495942-41495992	U87	brain:	n/a
35	chr19:41497222-41497272	PANC-1	pancreas:	n/a
36	chr19:41497222-41497272	U87	brain:	n/a
37	chr19:41496043-41496093	HepG2	liver:	n/a
38	chr19:41495942-41495992	H1-hESC	embryonic stem cell:	embryo
39	chr19:41495942-41495992	NB4	blood:	n/a
40	chr19:41496043-41496093	AG09319	gingival:	n/a
41	chr19:41497222-41497272	AG09319	gingival:	n/a
42	chr19:41496749-41496799	SAEC	small airway:	n/a
43	chr19:41496043-41496093	Hela-S3	cervix:	n/a
44	chr19:41496043-41496093	HCPEpiC	choroid plexus:	n/a
45	chr19:41495942-41495992	Caco-2	colon:	n/a
46	chr19:41496043-41496093	PFSK-1	brain:	n/a
47	chr19:41496749-41496799	ProgFib	skin:	n/a
48	chr19:41495942-41495992	GM19239	blood:	n/a
49	chr19:41496749-41496799	NT2-D1	testis:	n/a
50	chr19:41495942-41495992	AG09319	gingival:	n/a

No.	Distal block	Cell Line	Cell type
1	chr19:41463243..41465087-chr19:41467190..41469905,2	K562	blood:
2	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:
3	chr19:41435849..41437489-chr19:41440022..41442246,2	MCF-7	breast:
4	chr19:41480596..41481177-chr19:41649752..41650983,4	K562	blood:
5	chr19:41429883..41432599-chr19:41435321..41438137,2	MCF-7	breast:
6	chr19:41438993..41440711-chr19:41442295..41445002,2	MCF-7	breast:
7	chr19:41458951..41460963-chr19:41463374..41465958,2	K562	blood:
8	chr19:41463243..41465087-chr19:41467190..41469905,2	K562	blood:
9	chr19:41436490..41439337-chr19:41447432..41449781,2	MCF-7	breast:
10	chr19:41463496..41465246-chr19:41466230..41468956,2	K562	blood:
11	chr10:94639799..94640373-chr19:41475219..41475719,2	K562	blood:
12	chr19:41455358..41456878-chr19:41467418..41469286,2	K562	blood:
13	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:
14	chr19:41463496..41465246-chr19:41466230..41468956,2	K562	blood:
15	chr19:41458951..41460963-chr19:41463374..41465958,2	K562	blood:
16	chr19:41438993..41440711-chr19:41442295..41445002,2	MCF-7	breast:
17	chr19:41444451..41445965-chr19:41446160..41448128,2	MCF-7	breast:
18	chr19:41480412..41481100-chr19:41650028..41650578,2	MCF-7	breast:
19	chr19:41455358..41456878-chr19:41467418..41469286,2	K562	blood:
20	chr19:41436490..41439337-chr19:41447432..41449781,2	MCF-7	breast:
21	chr19:41433604..41436108-chr19:41440713..41443622,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2B6-1	chr19:41492504-41492600	l_1687_chr19:41492503-41503928_testes
2	lnc-CYP2B6-2	chr19:41453006-41453355	ENSG00000269353.1
3	lnc-CYP2B6-1	chr19:41493956-41494534	l_1687_chr19:41492503-41503928_testes
4	lnc-CYP2B6-1	chr19:41495264-41495408	l_1687_chr19:41492503-41503928_testes
5	lnc-CYP2B6-1	chr19:41493177-41493736	l_1687_chr19:41492503-41503928_testes
6	lnc-CYP2B6-2	chr19:41452252-41452450	ENSG00000269353.1

Variant related genes	Relation type
CYP2B6	TF binding region
ENSG00000269353	TF binding region
CYP2B7P	TF binding region
CYP2B6	CpG island
ENSG00000269353	CpG island
CYP2B7P	CpG island
ENSG00000256612	chromatin interactions

Extended variants
information (count: 2437 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:2437 , 50 per page) page: 1 2 3 4 5 6 7 ... 49

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs181149817	chr19:41437948-41437949	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs566208500	chr19:41438000-41438001	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs186000767	chr19:41438009-41438010	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs78790777	chr19:41438054-41438055	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs535152974	chr19:41438072-41438073	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs542427901	chr19:41438111-41438112	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs551193609	chr19:41438135-41438136	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs563217684	chr19:41438139-41438140	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs35781447	chr19:41438140-41438141	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs552909639	chr19:41438149-41438150	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs570820886	chr19:41438152-41438153	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs11667339	chr19:41438168-41438169	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs528469555	chr19:41438172-41438173	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs190855240	chr19:41438178-41438179	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs182530875	chr19:41438196-41438197	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs138437816	chr19:41438202-41438203	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs550331552	chr19:41438209-41438210	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs568712848	chr19:41438224-41438225	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs143813879	chr19:41438240-41438241	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs557620548	chr19:41438261-41438262	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs573138105	chr19:41438276-41438277	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs533533387	chr19:41438277-41438278	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs368380445	chr19:41438279-41438280	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs187606280	chr19:41438305-41438306	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs555377065	chr19:41438339-41438340	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs566832719	chr19:41438361-41438362	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs564882180	chr19:41438381-41438382	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs573622303	chr19:41438418-41438419	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs190795398	chr19:41438434-41438435	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs563828428	chr19:41438466-41438467	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs75969795	chr19:41438499-41438500	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs534047951	chr19:41438543-41438544	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs575922327	chr19:41438555-41438556	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs546462513	chr19:41438557-41438558	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs144252600	chr19:41438630-41438631	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs528813672	chr19:41438642-41438643	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs552672818	chr19:41438721-41438722	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs116971363	chr19:41438722-41438723	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs562133573	chr19:41438753-41438754	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs148721884	chr19:41438767-41438768	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs550669263	chr19:41438776-41438777	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs569049548	chr19:41438779-41438780	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs182950069	chr19:41438783-41438784	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs555360705	chr19:41438793-41438794	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs376132341	chr19:41438824-41438825	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs142206475	chr19:41438841-41438842	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs555036873	chr19:41438906-41438907	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs573586697	chr19:41438915-41438916	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs567154091	chr19:41438925-41438926	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs537902459	chr19:41438930-41438931	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	17431168	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:253 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41432200-41447600	Weak transcription	Liver	Liver
2	chr19:41437600-41438000	Enhancers	HUES6 Cell Line	embryonic stem cell
3	chr19:41437600-41439800	Enhancers	K562	blood
4	chr19:41437800-41438000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr19:41437800-41438000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr19:41437800-41438200	Genic enhancers	Fetal Intestine Small	intestine
7	chr19:41437800-41438600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr19:41437800-41438800	Enhancers	Fetal Intestine Large	intestine
9	chr19:41438000-41439400	Bivalent Enhancer	A549	lung
10	chr19:41438200-41438400	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr19:41438200-41438600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
12	chr19:41438200-41442000	Weak transcription	Fetal Intestine Small	intestine
13	chr19:41438400-41438800	Enhancers	Primary neutrophils fromperipheralblood	blood
14	chr19:41438400-41439000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
15	chr19:41438400-41439000	Enhancers	Placenta	Placenta
16	chr19:41438600-41439000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
17	chr19:41438600-41439600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
18	chr19:41438800-41444000	Weak transcription	Fetal Intestine Large	intestine
19	chr19:41439000-41439200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
20	chr19:41439000-41439200	Enhancers	Stomach Mucosa	stomach
21	chr19:41439000-41439800	Enhancers	ES-I3 Cell Line	embryonic stem cell
22	chr19:41439200-41447800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr19:41439200-41448000	Weak transcription	Stomach Mucosa	stomach
24	chr19:41439600-41439800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
25	chr19:41439800-41441600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
26	chr19:41440600-41442400	Weak transcription	Lung	lung
27	chr19:41441600-41441800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
28	chr19:41442000-41442400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr19:41442000-41445400	Strong transcription	Fetal Intestine Small	intestine
30	chr19:41442400-41442600	Strong transcription	Lung	lung
31	chr19:41442400-41451400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr19:41442600-41442800	Bivalent Enhancer	Stomach Smooth Muscle	stomach
33	chr19:41442600-41450200	Weak transcription	Lung	lung
34	chr19:41444000-41444800	Strong transcription	Fetal Intestine Large	intestine
35	chr19:41444400-41445400	Bivalent Enhancer	A549	lung
36	chr19:41444800-41455800	Weak transcription	Fetal Intestine Large	intestine
37	chr19:41445400-41450200	Weak transcription	Fetal Intestine Small	intestine
38	chr19:41445800-41449200	Enhancers	HUVEC	blood vessel
39	chr19:41446400-41446600	Enhancers	A549	lung
40	chr19:41446600-41446800	Flanking Active TSS	A549	lung
41	chr19:41446800-41447200	Enhancers	A549	lung
42	chr19:41447200-41447600	Bivalent Enhancer	A549	lung
43	chr19:41447400-41448000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr19:41447600-41447800	Flanking Bivalent TSS/Enh	A549	lung
45	chr19:41447600-41448200	Strong transcription	Liver	Liver
46	chr19:41447800-41448200	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr19:41447800-41448200	Bivalent Enhancer	A549	lung
48	chr19:41447800-41448200	Bivalent Enhancer	K562	blood
49	chr19:41448200-41449600	Weak transcription	Liver	Liver
50	chr19:41449600-41451800	Strong transcription	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links